Changes in nutrient proteins, inflammatory factors and immunoglobulins before and after enteral nutritional support in patients with cerebral hemorrhage
Abstract
Objective: Enteral nutrition support (ENS) is one of the necessary measures after surgical treatment of modern cerebral hemorrhage (CH), and this study will analyze the changes in nutrient proteins, inflammatory factors, and immunoglobulins before and after ENS in patients with CH, which will serve as a reference for future clinics when performing ENS.
Methods: 160 ICH patients (76 in the intermittent group and 84 in the continuous group) were included, and changes in indicators before and after EN intervention were retrospectively analyzed in both groups. Including nutrient proteins (albumin ALB, transferrin TRF, prealbumin PAB), inflammatory factors (IL-1β, IL-6, TNF-α), immunoglobulins (IgA, IgG, IgM) and gastrointestinal tolerance.
Results: There was no difference in adverse reactions between the two groups during ENS (P>0.05).After ENS, ALB, TRF, PAB, IgA, IgG, and IgM were significantly increased in both groups, while IL-1β, IL-6, and TNF-α were decreased (P<0.05). After ENS, there was no difference in nutrient proteins between the two groups (P>0.05), but inflammatory factors were lower in the intermittent group than in the continuous group, while immunoglobulins were higher than in the intermittent group (P<0.05).
Conclusion: ENS constitutes the core mechanism of neuroprotection through a multilayered linkage of “metabolic substrate supply - intestinal barrier repair - immune phenotype remodeling - inflammatory signaling inhibition”.
Copyright (c) 2025 Xiaolu Tang, Wenjun Tan, Xiaoqiang Li
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.